J Biol Chem, Vol. 274, Issue 45, 32402-32410, November 5, 1999
Purification and Biophysical Characterization of a New [2Fe-2S]
Ferredoxin from Azotobacter vinelandii, a Putative [Fe-S]
Cluster Assembly/Repair Protein*
Yean-Sung
Jung
,
H. Samantha
Gao-Sheridan
§,
Jason
Christiansen¶,
Dennis R.
Dean¶, and
Barbara K.
Burgess
From the
Department of Molecular Biology and
Biochemistry, University of California, Irvine, California 92697 and the ¶ Department of Biochemistry, Virginia Polytechnic
Institute and State University, Blacksburg, Virginia 24061
 |
ABSTRACT |
During the purification of site-directed mutant
variants of Azotobacter vinelandii ferredoxin I (FdI), a
pink protein, which was not observed in native FdI preparations,
appeared to associate specifically with variants that had mutations in
ligands to FdI [Fe-S] clusters. That protein, which we designate
FdIV, has now been purified. NH2-terminal sequence analysis
revealed that the protein is the product of a previously described
gene, herein designated fdxD, that is in the A. vinelandii iscSUA operon that encodes proteins involved in
iron-sulfur cluster assembly or repair. An apoprotein molecular mass of
12,434.03 ± 0.21 Da was determined by mass spectrometry
consistent with the known gene sequence. The monomeric protein was
shown to contain a single [2Fe-2S]2+/+ cluster by
UV/visible, CD, and EPR spectroscopies with a reduction potential of
344 mV versus the standard hydrogen electrode. When overexpressed in Escherichia coli, recombinant FdIV
holoprotein was successfully assembled. However, the polypeptide of the
recombinant protein was modified in some way such that the apoprotein
molecular mass increased by 52 Da. Antibodies raised against FdIV and
EPR spectroscopy were used to examine the relative levels of FdIV and
FdI in various A. vinelandii strains leading to the
conclusion that FdIV levels appear to be specifically increased under
conditions where another protein, NADPH:ferredoxin reductase is also
up-regulated. In that case, the fpr gene is known to be
activated in response to oxidative stress. This suggests that the
fdxD gene and other genes in the iron-sulfur cluster
assembly or repair operon might be similarly up-regulated in response
to oxidative stress.
 |
INTRODUCTION |
In 1962 the isolation of the first iron-sulfur ([Fe-S]) protein,
Clostridium pasteurianum ferredoxin, was reported (1). Within a few years it was clear that a new class of proteins had been
discovered containing clusters composed of Fe and S2
atoms ligated to the protein by cysteine ligands (2). Since that time
there has been an exponential growth in the discovery of new [Fe-S]
proteins that has exploded recently due to gene sequencing. Today, over
100 different types of [Fe-S] proteins have been isolated from all
life forms, from the most primitive archaea and bacteria to the most
advanced eucaryotes (3-9). These structurally diverse proteins are
involved in critical electron transfer reactions, chemical catalysis of
hydration/dehydration reactions (10-11), regulation of gene expression
(12-18), oxygen and iron sensing (12-16, 19), or the generation and
stabilization of radical intermediates (20-23).
The multiplicity of [Fe-S] cluster structures is remarkable (3-9,
24-25) with the simplest clusters containing 1, 2, 3, or 4 iron atoms.
Much of what we know about these protein-bound clusters comes from
studies of a class of [Fe-S] proteins collectively known as
ferredoxins. Ferredoxins are loosely defined as small, soluble,
generally acidic [Fe-S] proteins that function to transfer electrons
from one protein to another (2-9). In the past, it was believed that a
single ferredoxin was a relatively nonspecific electron transfer agent
that could participate in a number of different cellular processes
(26), and it is still common to see the term "bacterial ferredoxin"
or "plant ferredoxin" used in this generic sense. However, it is
now clear that a single organism can contain numerous different types
of ferredoxins, each of which is expected to have a specific function
in the cell.
Table I shows that the organism of
interest in this study, Azotobacter vinelandii, appears to
synthesize at least 12 different small, ferredoxin-like proteins. Only
a few of these proteins have been purified and characterized to date
(28-31, 34-35, 43-44) with others identified based on sequence motif
and/or homology with proteins that have been purified from other
organisms. One protein of particular relevance to this study was
initially identified by Zheng et al. (32) who sequenced a
gene cluster from A. vinelandii that encoded proteins that
are likely to be involved in the assembly of [Fe-S] clusters. Within
that gene cluster was a gene they designated fdx (Table I).
That gene was expected to encode a [2Fe-2S] ferredoxin because it was
homologous both in sequence and gene location to a [2Fe-2S]
ferredoxin that had been purified previously from Escherichia coli (45).
For several years now we have been using a different ferredoxin, the
extremely well characterized 7Fe
FdI1 from A. vinelandii (Table I), as a model to address certain basic
questions in [Fe-S] protein biochemistry (46-50). The general approach has been to construct, purify, and characterize numerous site-directed mutant variants of FdI. In the course of these studies we
have observed that some, but not all variants of FdI, appear to
copurify with a contaminating pink protein that is not seen during the
purification of native FdI. Here we report the purification and
characterization of that pink protein and its identification as the
product of the fdx gene that is cotranscribed with genes encoding proteins that appear to be involved in the assembly of [Fe-S] clusters.
We have chosen to designate the pink protein as FdIV because FdI (28,
33-36), a [2Fe-2S]-containing protein that is designated [Fe-S] II
but is sometimes referred to as FdII (28, 30-31), and FdIII (43) have
all been characterized extensively from A. vinelandii. We
suggest that the FdIV gene designation be changed from fdx to fdxD, in keeping with the FdI, fdxA
nomenclature, reserving fdxC for the FdIII gene when it
becomes available.
 |
EXPERIMENTAL PROCEDURES |
Strains--
The A. vinelandii strains used in this
study include AvOP that synthesizes native FdI at wild-type
levels, LM100 which has a kanamycin resistance cartridge inserted in
the fdxA gene and does not synthesize any FdI (33), and a
number of strains that were designed to overexpress specific
site-directed mutant variants of FdI using the previously described
pKT230 system (51). The variants used here are C42D (52), C20S (49),
C49S (52),
T14/
D15 (50), and C39S (52). It should be noted that
as indicated in the text, all of these proteins accumulate at much lower levels than native FdI such that the levels produced by the
overproduction strains are approximately equivalent to, or less than,
the levels of native FdI produced by wild-type A. vinelandii.
Protein Purification--
All A. vinelandii cells
were grown under N2-fixing conditions in a 200-liter New
Brunswick fermentor (48). The protein purification was carried out at
room temperature, and fractions were monitored by their absorbance at
405 nm. FdIV was purified from the strain overexpressing the C42D
variant of FdI, because, as indicated below, that strain has the
greatest accumulation of FdIV. The preparation was carried out
anaerobically in the presence of 2 mM
Na2S2O4 except the final
Mono-Q/FPLC column step. Cell-free extracts were prepared from 1 kg of
cells, and the first DEAE-cellulose column was run as described
previously for the purification of other FdI variants (51). From the
first DEAE-cellulose column (51) the FdI fraction eluted at 70-80% of
the linear 0.1-0.5 M NaCl gradient as a very shallow, yet
well resolved brown peak. The protein fraction was immediately diluted
with 2 or 3 volumes of 0.1 M potassium phosphate buffer, pH
7.4, and loaded onto a 2.5 × 5-cm DEAE-cellulose column that was
preequilibrated with the same buffer. Following loading, the column was
washed slowly at the elution rate of 1.5 ml/min for 5 h with 0.12 M KCl in the same buffer until a greenish-brown protein
(FdIII) (43) eluted. The pink-colored fraction containing FdIV, which
was visible on the column immediately following the greenish-brown
protein, was then eluted with 0.3 M KCl. Ammonium sulfate
was added slowly to 75% saturation with stirring. After a 30-min
incubation the sample was centrifuged at 20,000 × g
for 20 min. The pellet was then collected and resuspended in 0.025 M Tris-HCl, pH 7.4, before loading onto a 1.5 × 110-cm Sephadex G-75 (Amersham Pharmacia Biotech) column
preequilibrated with 0.025 M Tris-HCl, pH 7.4, and 0.1 M NaCl. FdIV and FdI eluted as a single broad peak as observed by monitoring absorbance at 405 nm; however, FdIV actually moved slightly faster than FdI. For that reason the first third of the
peak was collected and concentrated using a Centriplus-10 concentrator
(Amicon) prior to further purification on a 1-ml Mono-Q/FPLC column
(Amersham Pharmacia Biotech) with a flow rate of 1 ml/min and a linear
gradient of 0.3-0.8 M NaCl in 0.05 M Tris-HCl,
pH 8.0, over 20 ml. Two fractions were well resolved as follows: the
red-colored FdIV fraction that eluted between 0.46 and 0.48 M NaCl, and a brown-colored FdI fraction that eluted between 0.54 and 0.58 M NaCl. The pink-colored FdIV
fraction became red-colored when it was air-oxidized. Each fraction was
collected, buffer-exchanged with 0.025 M Tris-HCl, pH 7.4, concentrated to 0.5 ml, and kept in the
20 °C freezer until use.
The yield for FdIV is ~0.5 mg per kg C42D cell.
Overproduction of FdIV in E. coli--
Overproduction of FdIV in
E. coli was accomplished by constructing a fdxD
gene cartridge in vitro and cloning this cartridge into the
pT7-7 plasmid (53) such that fdxD gene
expression was controlled by the T7 phage transcriptional
and translational regulatory elements. The fdxD gene
cartridge was constructed by using an isolated 1.0-kilobase pair DNA
fragment that was generated by EcoRI restriction enzyme
digestion of an isolated fragment of A. vinelandii strain
DJ116 (
nifS) chromosomal DNA (32). This DNA fragment was
cloned into pUC119, and the plasmid was designated pDB946. pDB946 was
subsequently used as a template for PCR amplification of the
fdxD coding sequence. PCR amplification of fdxD
was performed essentially as recommended by the supplier of Amplitaq
(Perkin-Elmer). Cycling temperatures were 95 °C for 1 min, 60 °C
for 2 min, and 72 °C for 3 min. The PCR primers used were
5'-CATGCATATGCCGCAGATCGTTTTTC-3' and
5'-CTACGGATCCCTCAGTGCTGTTCC-3'. The amino acid coding region for FdIV
is underlined in the first primer sequence shown above. Following
fdxD amplification, the gene cartridge was digested with the
restriction enzymes NdeI and BamHI and ligated to
NdeI- and BamHI-digested pT7-7 DNA.
Proper orientation of fdxD within the resulting hybrid
plasmid (pDB1024) such that the T7 gene-10 promoter directs
fdxD transcription was confirmed by restriction enzyme
digestion of isolated plasmid DNA. For isolation of FdIV overproduced
in E. coli, plasmid pDB1024 was transformed into the host
strain BL21(DE3), and the transformed cells were maintained on LB media
supplemented with 100 µg/ml ampicillin. Cells were grown in 500-ml
batches in LB media at 30 °C and were induced for FdIV production at
approximately 160 Klett units (red filter) by the addition of lactose
to 1% (w/v) final concentration. Following addition of lactose, cells
were cultured for an additional 2 h, harvested by centrifugation,
and frozen at
20 °C until use.
The purification of recombinant FdIV was carried out aerobically.
E. coli cells containing the overproduced FdIV were ruptured by sonication in 0.025 M Tris-HCl, pH 7.4. Extracts were
then ultracentrifuged in a Beckman Ty35 rotor at 35,000 rpm for 20 min
at 4 °C. Cell-free lysate was then loaded onto a 1.5 × 14-cm Q-Sepharose (Amersham Pharmacia Biotech) column equilibrated in 0.025 M Tris-HCl, pH 7.4, and 0.1 M NaCl. After
loading, a gradient of 5 column volumes from 0.1 to 0.6 M
NaCl was run. The red protein eluted at approximately 0.5 M
NaCl, and the peak fractions were loaded onto a 5 × 44-cm
Sephacryl S-300HR (Amersham Pharmacia Biotech) equilibrated and run in
0.025 M Tris-HCl, pH 7.4, and 0.1 M NaCl.
Column eluents were monitored at A405 using an
Amersham Pharmacia Biotech UV-1 optical detector and control unit.
Protein Sequencing and Determination of Molar Extinction
Coefficient--
The NH2-terminal protein sequencing was
carried out at the Biotechnology Resource Facility at the University of
California, Irvine, and also at the W. M. Keck Facility at Yale
University. The protein samples used for protein sequencing at the
University of California, Irvine, were obtained by excising the
predominant protein band of an FdIV sample from a Coomassie
Blue-stained SDS-12% PAGE and eluting the protein into 10 mM ammonium bicarbonate. The protein sample was then
modified using 2-mercaptoethanol and 4-vinylpyridine so that the
modified cysteines could be detected. The sample used for sequencing at
Yale University was prepared by excising the protein band from a
Coomassie Blue-stained polyvinylidene fluoride membrane (Millipore)
onto which an FdIV sample resolved in an SDS-12% PAGE was
electroblotted. Twenty seven residues were solved at the University of
California, Irvine
(PQIVFLPHEVHCPQGRVVEAATGTSIL, note that the underlined residues were identified with ambiguity). Twenty residues were identified at Yale University,
PQIVFLPHEVHCPQGRVVEA. The molecular weight of FdIV was determined at
the W. M. Keck Facility at Yale University using
quadruple-time-of-flight mass spectrometry using an
electrospray interface. The electrospray ionization technique was
preferentially chosen with the hope of detecting signals corresponding
to both holoprotein with the [Fe-S] cluster bound and the apoprotein.
The mass spectrometry using MALDI ionization technique was performed at
the Biotechnology Resource Facility at the University of California,
Irvine. Quantitative triplicate amino acid analyses of Mono-Q/FPLC
purified FdIV was carried out at the W. M. Keck Facility at Yale
University. The protein content for determination of the molar
extinction coefficient was estimated from the nanomoles of Ala, Leu,
and Phe using the composition and Mr 12,375 (for
apoprotein) calculated from the gene sequence and was corrected for
holoprotein. Here the cluster composition was determined.
Protein Characterization--
The antibody for FdIV was produced
in rabbits in Bethyl Laboratories, Inc. (Montgomery, TX), using routine
immunization protocols. The final antiserum was obtained 1 week after
the sixth antigen was injected into the rabbit. To determine iron
content, samples were digested, and the analysis was carried out as
described previously using FeCl3·6H2O to
generate a standard curve with FdI and FdIII as controls (54). Redox
titration of FdIV was performed spectrophotometrically at room
temperature using 5'-deazariboflavin/potassium oxalate as a
photoreductant system and benzyl viologen as a chemical mediator (E0' =
320 mV versus standard
hydrogen electrode) as described (55). The sample was anaerobically
prepared in a glove box (oxygen level < 1 ppm) and was sealed
with a rubber stopper and an aluminum cap. A 1-cm light path cuvette,
in a 1-ml volume, contained 5 µM 5'-deazariboflavin, 15 mM potassium oxalate, 45 µM benzyl viologen, and 40 µM FdIV in 0.05 M Tris-HCl, pH 8.0. The mixture was exposed to the light of a slide projector (5-300 s),
and absorbance changes were monitored after 30 s equilibration in
darkness. A water-containing vessel was installed between the sample
and light source to avoid overheating the sample during the
illumination. The percentage of [2Fe-2S] cluster reduction was
determined from the absorbance change at 440 nm, which is an isosbestic
point between the oxidized and reduced forms of benzyl viologen. The
total reduction of [2Fe-2S] was estimated from the absorbance change
after 2 mM Na2S2O4 was added to sample. The extent of benzyl viologen reduction was calculated from the absorption at 600 nm after correction for the absorbance of Fd
at this wavelength.
EPR spectra were obtained using a Bruker ESP300E spectrometer,
interfaced with an Oxford liquid helium cryostat. The EPR measurement for spin quantitation was performed either at 30k for 100 µM purified FdIV or 25k for 100 µM
recombinant FdIV at microwave power where the EPR signal of FdIV is
linearly proportional to (power)1/2. Cu2+-EDTA
(100 µM), which was used as a standard, was recorded at the same EPR setting and temperature, where the signal is also linearly
increasing as a function of (power)1/2. The concentration
of spin was calculated by double integration of signal over the entire
sweep width (56). For anaerobic EPR measurement, the samples were
loaded into the EPR tubes in an O2-free (O2 < 1 ppm) glove box (Vacuum Atmosphere, Hawthorne, CA). The tubes were
sealed with a cap, wrapped with parafilm, and then transferred to a
liquid nitrogen Dewar.
Absorption spectra were recorded in 0.5-ml quartz cuvettes on a
Hewlett-Packard 8452A diode array spectrophotometer. CD spectra were
obtained using a Jasco J-500C spectropolarimeter. CD measurements were
carried out using small volume cylindrical cells with fused quartz windows.
Attempted Insertional Inactivation of fdxD Gene in A. vinelandii--
Kanamycin resistance cartridges were inserted into the
fdxD gene in order to disrupt its transcription. Plasmid
pDB946 was digested with EcoRV, and kanamycin cartridges
derived from pUC-KAPA were inserted. Kanamycin cartridges were inserted
so that they are transcribed in the same (pDB1015) or opposite
orientation (pDB1016) as the fdxD gene.
The Level of Both FdIV and FdI in FdI Variants--
EPR and
Western blot methods were performed to quantify the amount of FdIV and
FdI present in the cell. Because of the low abundance of protein in
whole cells, we prepared concentrated protein samples in the following
way. The same amount (350 g) of cell paste from site-directed variants
(C42D, C20S, and
T14/
D15), LM100 (FdI deletion), and
AvOP (containing wild-type FdI) was thawed, broken, and
centrifuged at 8,000 rpm for 2 h. The supernatant was loaded onto
a 2.5 × 15-cm anion exchange (DE52, Whatman) column equilibrated
with 0.05 M Tris-HCl, pH 8.0. The column was washed with 2 volumes of 0.025 M Tris-HCl, pH 7.4, followed by 300 ml linear gradient from 0.1 to 0.5 M NaCl. FdIV and FdI eluted
together as a single peak as monitored by A405.
The peak was collected and concentrated to ~5 ml in an Amicon cell
fitted with a YM-3 membrane.
 |
RESULTS AND DISCUSSION |
How FdIV Came to Our Attention--
Over the past several years we
have purified, or attempted to purify, a large number of site-directed
mutant variants of the 7Fe FdI from A. vinelandii (47-50,
52). Many of these proteins presented unique purification challenges,
but in all cases our initial attempts began with a procedure that was
developed for native FdI involving a first column separation on
DEAE-cellulose with a linear NaCl gradient. In all cases the columns
were monitored by measuring the absorbance at 405 nm, and in all cases
an FdI peak was observed in the expected position, relative to internal marker proteins, the MoFe and Fe proteins of nitrogenase (51, 54). The
size of the absorbance peak varied depending upon how much of a
particular FdI variant accumulated in vivo, but the position
of the peak was invariant. It was upon going to the second step, using
another DEAE-cellulose column, or the third step, using a size
exclusion column (Sephadex G-50), that significant differences in the
color of the FdI fractions were observed. For some, but certainly not
all variants, the protein fractions appeared pink, instead of the
normal brown color for native FdI. Often in these cases it was never
possible to purify successfully the FdI variant, or the FdI variant was
ultimately purified only with great difficulty and in very low yield.
Table II summarizes the qualitative
observations obtained by us over the past several years.
While purifying the FdI [4Fe-4S] cluster ligand variant, C42D, we
observed that even the first column FdI fraction appeared to be pink
and that a large amount of pink material eluted from subsequent columns
in the same fractions as the C42D FdI which we were identifying by
cross-reaction to FdI antibodies. To determine whether the pink color
arose from an unusual form of FdI or from a contaminating protein, a
variety of purification methods was employed in attempts to separate
the pink color from C42D FdI. As described under "Experimental
Procedures," FdIV was ultimately separated from partially purified
C42D FdI on a Mono-Q/FPLC column to give a fraction that ran as a
single band on SDS-PAGE that did not react with FdI antibody. A routine
purification procedure was then developed to yield about 0.5 mg of FdIV
per kg of C42D cell paste.
As shown in Fig. 1, purified FdIV runs on
an SDS-12% polyacrylamide gel at a position corresponding to
~25,000, slightly slower than native FdI. It has previously been
observed that FdI migrates abnormally on SDS-12% PAGE as if its
molecular weight were ~24,000 rather than 12,000 (57). Such anomalous
behavior on SDS-PAGE has previously been reported for other small and
highly charged proteins (the isoelectric point of FdI calculated from
amino acid sequence is 4.03) (58). The similar purification properties and electrophoretic behaviors of FdIV and FdI suggested that they were
likely to have similar charges and molecular weights. As expected, FdIV
is a monomer that it runs on Superdex 75/FPLC with almost the same
retention time as FdI, which is monomer. It is also a highly acidic
protein. The isoelectric point calculated from the amino acid sequence
as shown in Fig. 2 is 4.29. Once FdIV was
purified, antibodies were raised against it, and the antiserum does not
cross-react with FdI (data not shown).

View larger version (87K):
[in this window]
[in a new window]
|
Fig. 1.
SDS-12% polyacrylamide gel electrophoresis
separation of the purified FdIV. Lane a,
Mono-Q/FPLC-purified FdIV; lane b, native FdI; lane
c, FdIII; last lane, molecular marker. The
numbers shown on the right indicate the molecular
mass (kDa) represented by the marker.
|
|

View larger version (63K):
[in this window]
[in a new window]
|
Fig. 2.
Comparison of partial FdIV sequence to the
translated sequences of several [2Fe-2S] ferredoxin genes.
Ava, amino acid sequence of FdIV obtained in
this study; Avb, translated from the A. vinelandii fdx gene (32); Pa, translated from the
P. aeruginosa fdx gene (59); Ec, translated from
the E. coli ferredoxin gene (45, 60); Hi,
translated from the H. influenzae Rd fdx-1 gene
(61); Ba, translated from the B. aphidicola
ferredoxin gene (62); Vc, translated from the V. cholerae unfinished fragment of complete genome; Sp,
translated from the S. putrefaciens unfinished fragment of
complete genome; St, translated from the S. typhi
unfinished fragment of complete genome; Yp, translated from
the Y. pestis unfinished fragment of complete genome;
Pm, translated from the P. multocida PM70
unfinished fragment of complete genome; Bp, translated from
the B. pertussis unfinished fragment of complete genome;
Nm, translated from the N. meningitidis serogroup
A unfinished fragment of complete genome; Ng, translated
from the N. gonorrhoeae unfinished fragment of complete
genome; Aa, translated from the A. actinomycetemcomitans unfinished fragment of complete genome. The
predicted cysteine ligands to the [2Fe-2S] cluster are indicated by
both bold letters and arrows.
|
|
Identification of FdIV--
For identification, the gel-purified
protein was subjected to NH2-terminal protein sequencing
with cysteine modification. Twenty residues were unambiguously
identified, PQIVFLPHEVHCPEGRVVEA. Sequence homology searches in the
data base Protein Data Base + SwissProt + PIR + GenBankTM
translations were performed. As shown in Fig. 2, the results revealed
the presence of a sequence with a perfect match in A. vinelandii (32), and sequences with high identity in
Pseudomonas aeruginosa (59), E. coli (45, 60),
Hemophilus influenzae (61), and Buchnera
aphidicola (62). Searches in the Unfinished Microbial Genome data
base have found similar sequences in Vibrio cholerae,
Shewanella putrefaciens, Salmonella typhi,
Yersinia pestis, Pasteurella multocida,
Bordetella pertussis, Neisseria meningitidis,
Neisseria gonorrhoeae, and Actinobacillus
actinomycetemcomitans. Sequence comparisons indicate that FdIV is
the gene product of the fdx gene in the A. vinelandii
iscSUA operon and consists of 111 residues with 12,435 Da
(deduction from the amino acid sequence) with the first 2 Mets missing
in the purified protein (Fig. 2). The molecular mass determined by
electrospray mass spectrometry was 12,434.03 ± 0.21 Da, which can
be attributed to apoprotein (average mass 12,435 Da) (data not shown).
We further confirmed this by observing the same molecular mass for the
fdx gene product with MALDI ionization techniques (data not
shown). The MALDI technique requires use of an organic chemical matrix
(saturated sinapinic acid was used in this study) dissolved in 30%
acetonitrile and 0.1% trifluoroacetic acid (63). That procedure is
expected to destroy the iron-sulfur cluster. Therefore the molecular
mass obtained from the MALDI techniques should correspond to the
apoform, which it does. Unlike what has been reported for other
[Fe-S] proteins (64-66), in this electrospray mass spectrometry
study we could not detect the second peak corresponding to holoprotein at 178 Da above that of the apoprotein, 12,435 Da.
FdIV Contains a [2Fe-2S]2+/+ Cluster--
Of the
proteins shown in Fig. 2 only the protein from E. coli has
been purified and characterized and shown to contain a single [2Fe-2S]2+/+ cluster (45). In that case the four cysteine
ligands to the cluster were suggested to be those shown in Fig. 2 based
on comparison with human (67) and Pseudomonas putida (68)
ferredoxins whose [2Fe-2S]2+/+ clusters are known to be
ligated by a
Cys-X5-Cys-X2-Cys-X35-Cys motif. This pattern is highly conserved among all 14 sequences shown in
Fig. 2. In addition, the sequences around the four cysteine residues in
the motif are also highly similar. If these four cysteines are indeed
the ligands for [2Fe-2S]2+/+ clusters, this pattern
represents a subclass of ferredoxin-type [2Fe-2S]2+/+
cluster binding motifs, which is shared by "vertebrate or
bacterial"-type ferredoxins (45, 69-70). This is in contrast to the
Cys-X4-Cys-X2-Cys-X29 or 30-Cys motif found in "plant"-type Fds, which participate in
photosynthetic electron transfer processes in plants and in blue-green
algae (71-72). The pink color of Fd IV, as well as its sequence, is
consistent with the protein containing a [2Fe-2S]2+/+
cluster as a prosthetic group. The nature of this center was therefore
investigated and identified by spectroscopic analyses and biochemical methods.
Iron content analysis for FdIV gives 2.0 ± 0.1 iron atoms per
molecule when the
458 = 7,071 M
1 cm
1, determined from
triplicate amino acid analysis for protein quantitation. In the same
assay, the 7Fe containing FdI and 8Fe containing FdIII gave 7.0 ± 0.1 and 7.7 ± 0.1 iron atoms per molecules, respectively. These
results indicate that FdIV contains either a [2Fe-2S] cluster or two
rubredoxin-like 1Fe centers. The possibility of having two
rubredoxin-like iron centers was ruled out because FdIV contains only 6 cysteine residues per molecule, which cannot accommodate formation of
two rubredoxin-like 1Fe centers. This is further supported by the
observation that we could not detect any EPR signal with g
values of 4.3 and 9.5, which arise from the 3/2 and 1/2 kramers'
doublets, respectively, of an S = 5/2 multiplet of
rubredoxin in the dithionite-reduced state (data not shown) (73-74).
The UV/visible spectrum of oxidized FdIV, shown in Fig.
3, is distinct from those obtained for
7Fe FdI and 8Fe ferredoxins (such as FdIII) (43) and is
indistinguishable from that of bacterial type [2Fe-2S] ferredoxins,
exhibiting peaks at 414 and 458 nm and a broad maximum with a shoulder
near 322 and 337 nm (45). The extinction coefficient of 7,071 M
1 cm
1 at 458 nm is a little
lower than those obtained for other [2Fe-2S] Fds that are reported to
be between 8,000 and 10,000 M
1
cm
1 (75-76). Upon reduction of FdIV with 2 mM dithionite, the absorbance in the visible region is
greatly reduced, and characteristically, a new peak at 545 nm which
makes FdIV turn "pink" in color appears (55, 77). Such a spectral
feature has previously been observed for the closely related E. coli [2Fe-2S]+ Fd and the bacterial type
[2Fe-2S]+ FdV from Rhodobacter capsulatus, but
not for plant-type [2Fe-2S]+ ferredoxins (77). The
spectrum of oxidized FdIV is recovered when reduced FdIV is exposed to
air (data not shown), indicating that the protein is stable in the
presence of O2.

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 3.
UV/visible absorption spectrum of FdIV.
Solid line, air-oxidized; dotted line, reduced in
the 2 mM sodium dithionite for 30 min.
|
|
The CD spectra of oxidized and dithionite-reduced FdIV, shown in Fig.
4, are very similar to those of other
[2Fe-2S]2+/+ ferredoxins (45, 77). The [2Fe-2S] cluster
exhibits intense visible CD compared with other biological [Fe-S]
clusters, and CD spectra are more sensitive than the corresponding
absorption spectra to the protein folding in the vicinity of the
cluster (78-79). For the oxidized protein the negative peaks at 550 and 500 nm, and large positive peaks at 435 nm, with a shoulder, are characteristic features of [2Fe-2S]2+ clusters. This
[2Fe-2S]2+ CD spectrum is quite different from those
exhibited by 7Fe or 8Fe ferredoxins (43, 57). The presence of a
shoulder in the main peak and the separate bands in the range from 250 to 350 nm are also used to differentiate between plant-type
[2Fe-2S]2+ ferredoxins and vertebrate or bacterial-type
[2Fe-2S]2+ ferredoxins. Again the environment around the
[2Fe-2S]2+ cluster in FdIV, as observed by CD, is quite
similar to vertebrate or bacterial-type ferredoxins.

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 4.
Visible region CD spectrum of FdIV.
Solid line, air-oxidized; dotted line, reduced in
2 mM sodium dithionite for 30 min. The samples were
suspended in 0.025 M Tris-HCl, pH 7.4, and 0.1 M NaCl.
|
|
EPR analysis of purified FdIV in the oxidized form shows no signal
(Fig. 5A). Upon reduction by
dithionite, the spectrum exhibits a nearly axial signal with apparent
g values of 2.03 and 1.95. This signal may be attributed to
a [2Fe-2S]+ cluster with an S = 1/2 spin
state (Fig. 5B), which comes from the anti-ferromagnetic
coupling of ferric S = 5/2 and ferrous S = 2 spin states. Spin integration of the EPR signal
of spectrum B in Fig. 5 and comparison with 0.1 mM Cu2+-EDTA standard gives a value of about
1.03 spin/mol of protein, thus providing further evidence that FdIV
contains a [2Fe-2S] cluster. The axial EPR signal is again
characteristic of vertebrate or bacterial-type 2Fe ferredoxins, whereas
the spectra of plant-type 2Fe ferredoxins reveal a distinct rhombic
distortion (45). The temperature dependence of the EPR signal
originating from this [2Fe-2S]+ cluster showed an optimum
of 30k, and almost half of the signal intensity was still detectable at
temperatures as high as 70k (data not shown). The power saturation
dependence is further consistent with a [2Fe-2S]+ cluster
(data not shown). Taken together, the power and temperature dependence
rule out the possibility that the EPR signal arises from a
[4Fe-4S]+ cluster.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 5.
X-band EPR spectra of FdIV in the
air-oxidized state (A) and reduced state
(B). The samples were 100 µM in
0.05 M Tris-HCl, pH 8.0, and 0.1 M NaCl. The
reduced sample was in 2 mM sodium dithionite. Conditions of
measurements are as follows: microwave frequency, 9.49 GHz; modulation
amplitude, 0.64 mT; microwave power, 1 milliwatt; and temperature, 30 K; receiver gain, 2 × 104.
|
|
The oxidation-reduction potential of the FdIV
[2Fe-2S]2+/+ cluster was measured by anaerobic titration
using benzyl viologen as a potential indicator and
5'-deazariboflavin/potassium oxalate as a photoreductant. The
absorbance change was measured at 440 nm to eliminate the contribution
of benzyl viologen to the signal as described under "Experimental
Procedures." By using the Nernst equation (Equation 1) and plotting
the Eh versus the log([FdIVox]/[FdIVred]), the midpoint redox
potential was calculated to be approximately
344 ± 10 mV
versus standard hydrogen electrode at pH 7.8 (best fitted
with a slope of 52 mV in case of n = 1) (Fig.
6).
|
(Eq. 1)
|
The potential is similar to the related E. coli
[2Fe-2S]2+/+ Fd, which was known to be approximately
380 mV (77) and is within the range of other
[2Fe-2S]2+/+ ferredoxins.

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 6.
Determination of the midpoint redox potential
of purified FdIV by spectrophotometric titration. Light in the
presence of 5'-deazariboflavin/potassium oxalate was illuminated
incrementally from 5 to 300 s to an anaerobic cuvette containing
purified FdIV and benzyl viologen as described under "Experimental
Procedures." At each point, the concentrations of the oxidized forms
of the both FdIV and benzyl viologen were measured from their
absorbances and used to calculate Eh.
|
|
Comparison of FdIV Purified from A. vinelandii and Recombinant FdIV
from E. coli--
In order to obtain larger quantities of FdIV for
crystallization and affinity chromatography experiments (80), the
fdxD gene was used to construct a hybrid plasmid where the
expression of the fdxD was placed under the control of the
T7 transcriptional and translational control elements. As
described under "Experimental Procedures," FdIV was successfully
expressed in E. coli in soluble form using this system, and
the protein was easily purified with yields of ~0.8 mg per g of
cells. The air-oxidized, isolated gene product appeared to be
red-colored, indicating that the [2Fe-2S]2+/+ cluster was
successfully assembled into the polypeptide in E. coli. The
successful overproduction of several other ferredoxins in their native
forms in E. coli had previously been reported including the
[2Fe-2S]2+/+ adrenodoxin (81), a
[2Fe-2S]2+/+ ferredoxin from heterocysts of
Anabaena strain 7120 (82), the 2 [4Fe-4S]2+/+
ferredoxin from C. pasteurianum (83-84), and a [3Fe-4S]
[4Fe-4S] ferredoxin from R. capsulatus (85). To see
whether the FdIV [2Fe-2S]2+/+ cluster was correctly
assembled into the polypeptide, we characterized the recombinant FdIV
using the same spectroscopic and biochemical techniques we had used for
the native protein. The UV/visible spectra, CD spectra, EPR signal, and
the temperature and magnetic dependence of that signal of recombinant
FdIV were indistinguishable with those of purified FdIV (data not shown).
Given the identity of the spectra obtained for the recombinant and
native proteins, we were surprised to observe that they did not migrate
in the same place on SDS-PAGE. Fig. 7
shows that the recombinant protein migrates faster than the native
protein on SDS-12% PAGE indicating either that it is smaller or that
it has less negative charge or both. NH2-terminal
sequencing of recombinant FdIV showed that the sequence starts with Pro
as the first amino acid, as does the purified native FdIV (Fig. 2) so
the difference in migration behavior cannot be attributed to a
NH2-terminal deletion. The discrepancy between the two
proteins was confirmed by mass spectrometry (data not shown). As
indicated above, the mass of 12,434.03 ± 0.21 Da obtained for the
native apoprotein was as expected based on the gene sequence. In
contrast, a mass of 12,486.01 ± 0.89 Da, 52 Da mass units larger,
was obtained for the recombinant apoprotein. Thus the recombinant
protein appears to be modified in some way that makes it larger by 52 Da mass units, while making it run faster on SDS-PAGE suggesting that
the modification may involve the removal of negative charge or the
addition of positive charge. Another possibility is the formation of an
intra-molecular cross-link, which alters its mobility on the SDS-PAGE
and its molecular mass by 52. At present we are unable to identify the specific nature of the 52-Da modification; however, we do know that the
change does not affect either the assembly of the
[2Fe-2S]2+/+ cluster or the conformation of the protein
near the cluster because the spectral properties are not changed.

View larger version (72K):
[in this window]
[in a new window]
|
Fig. 7.
SDS-12% polyacrylamide gel electrophoresis
separation of the recombinant FdIV (a) and purified
FdIV (b). The samples were run on the same gel
but not next to each other. The numbers shown on the
right indicate the molecular mass (kDa) represented by the
marker.
|
|
Attempted Deletion of the fdxD Gene--
A.
vinelandii has a high frequency reciprocal recombination
system that has been used to disrupt a variety of nonessential genes
(e.g. fdxA and nifF). Disruption of
the fdxD gene was desired not only as a probe of the
function of the protein but also as a means of eliminating a tenacious
contaminant encountered during the purification of some FdI variants
(Table II). Wild-type A. vinelandii was transformed with
plasmids that would result, upon recombination, in strains that would
have the fdxD gene disrupted by the insertion of a kanamycin
resistance cartridge (see "Experimental Procedures"). However,
after initial selection for the kanamycin resistance phenotype, the
selected colonies were observed to revert back to kanamycin
sensitivity. This behavior indicates that the fdxD gene is
required for proper cellular function of A. vinelandii.
Relative Amounts of FdI and FdIV in Strains Expressing FdI
Variants--
The purification and characterization of FdIV described
above provides two new tools to examine the relative amounts of FdIV and FdI in various A. vinelandii strains. First, antibodies
raised separately against the two proteins can be used because each
antibody only cross-reacts with the protein it was raised against.
Based on the qualitative information shown in Table II, we selected three strains expressing FdI variants to compare with the wild-type strain AvOP. The strains expressing C20S FdI, C42D FdI, and
T14/
D15 were chosen because the levels of FdI accumulated by
these strains appeared to cover wide ranges of FdI accumulation,
roughly similar expression (
T14/
D15), a little lower FdI
expression (C20S FdI), and significantly lower FdI expression (C42D
FdI) when compared with the levels of FdI accumulated by the wild-type
strain, an observation that is confirmed by the comparison shown in
Fig. 8A. Therefore, it might
be possible to probe the relationship between FdI and FdIV by looking
at FdIV expression level in these strains. In addition, all three of
these proteins were stable enough to be purified (50, 52). Initially as
a control, we also compared the FdIV levels in LM100, an A. vinelandii strain that does not synthesize FdI.

View larger version (72K):
[in this window]
[in a new window]
|
Fig. 8.
Relative amounts of FdI (A)
and FdIV (B), detected by Western blot, in strains
expressing FdI variants. The same amount of protein (7 µg for
FdI and 30 µg for FdIV) was loaded in each lane. Top antibodies were
raised against FdI, and bottom antibodies were raised against FdIV.
WT, wild type AvOP.
|
|
Fig. 8B compares the levels of FdIV in the FdI fractions
collected from the first column for the A. vinelandii
strains we tested. The first surprise in this comparison is that the
levels of FdIV seem to be the greatest in LM100, the strain that does not synthesize any FdI. Another surprise is that significant FdIV was
observed using antibodies for wild-type and
T14/
D15 even though
none of the protein was observed during the purification of FdI from
those stains. In contrast, for C20S, which has FdI (Fig. 8A)
and FdIV levels comparable to wild-type (Fig. 8B), FdIV was
observed during the purification of FdI. At present we are unable to
explain why FdIV presents itself as a serious problem during the
purification of some FdI variants and not for others, but clearly there
is more to the problem than simply the relative levels of the two
proteins. The one observation shown in Fig. 8B that was
predicted in advance is that C42D does have more FdIV than the other strains.
One disadvantage of the Western blot method of comparison is that it
only provides semiquantitative information about the total protein
present and cannot distinguish apoprotein and/or cluster-converted
protein from holoprotein. Quantitative information about the relative
amounts of FdI and FdIV holoproteins in the various strains can be
obtained by EPR. This is possible because the [3Fe-4S]+
cluster of FdI exhibits a characteristic g = 2.01 EPR
signal in the oxidized state (Fig.
9A), conditions where FdIV is
diamagnetic. Upon reduction with dithionite the [3Fe-4S]0
cluster becomes EPR silent in the perpendicular mode, whereas the
[2Fe-2S]+ cluster from FdIV exhibits a characteristic
g = 1.95 EPR signal (Fig. 9B).

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 9.
Relative amounts of FdI (A)
and FdIV (B), detected by EPR, in strains expressing
FdI variants. Spectrum a, AvOP;
spectrum b, LM100; spectrum
c, C42D; spectrum d, C20S; and
spectrum e, T14/ D15 FdI variants. The same
amounts of protein were used, 0.36 and 0.18 mg, respectively, in
A and B. EPR conditions for FdI are as follows:
microwave frequency, 9.49 GHz; modulation amplitude, 0.64 mT; microwave
power, 1 milliwatt; and temperature, 10 K; receiver gain, 5 × 103. For measurement of FdIV [2Fe-2S]+, the
sample was first reduced in 2 mM sodium dithionite, and EPR
was carried out under the same condition as in FdI except change in
temperature and receiver gain into 35 K and 2 × 104,
respectively. A minor signal observed near gz of
[2Fe-2S]+ in all FdI mutants is unidentified but,
considering that the same signal is also observed in FdI-less LM100
strain, it does not represent [3Fe-4S]+ EPR signal of
FdI.
|
|
Fig. 9A compares the EPR spectra exhibited by the first
column FdI fractions for the strains of interest. Clearly the amount of
[3Fe-4S]+ containing FdI is highest in wild-type followed
by C20S with much lower levels observed for both C42D and
T14/
D15. In the latter case, however, it should be noted that the
low level of [3Fe-4S]+ cluster is not expected to
correlate with the levels of cross-reactive material present (Fig.
8A) because that mutation resulted in converting the FdI
[3Fe-4S] cluster to a [4Fe-4S] cluster which does not exhibit an
EPR signal in the oxidized state
(50).2 As expected, no FdI
was detected in LM100. The good correlation between FdI levels observed
with antibodies (Fig. 8A) and FdI levels observed by EPR
(Fig. 9B) for C42D and C20S FdI indicate that the fractions
contain mainly holoprotein. This is also consistent with the final
yields of holoprotein for these two mutants once these fractions were
purified to homogeneity.
The levels of FdIV observed by cross-reactivity with antibodies and by
EPR are also similar. Fig. 9B shows that the highest levels
of FdIV are observed in LM100 but significant levels are also observed
in the wild type. Also consistent with the information in Fig.
8B C42D has higher levels of FdIV than does the wild type, and the levels of FdIV in C20S and
T14/
D15 are lower.
Physiological Considerations--
Here we have reported the
purification and characterization of a new [2Fe-2S]2+/+
ferredoxin from A. vinelandii, FdIV, and the identification
of the protein as the product of a previously sequenced gene which we
now designate fdxD. This gene is located immediately
downstream of the iscSUA-hscBA gene cluster and appears to
be cotranscribed with this cluster (32). The iscSUA gene
products are likely to catalyze critical reactions in the assembly
and/or repair of [Fe-S] clusters. The hscBA gene products
may serve as the molecular chaperone proteins that assist in the
maturation of these [Fe-S] proteins (32). In this context it
therefore seems likely that FdIV is somehow involved in the processes
of [Fe-S] cluster formation and/or repair possibly by carrying out an
essential electron transfer step. Our inability to construct a
knock-out mutant further suggests that FdIV is essential for the
survival of the cell.
FdIV originally came to our attention because it appeared to associate
specifically with certain FdI variants that had altered [Fe-S] ligand
composition, an observation that would be consistent with its role in
[Fe-S] cluster assembly or repair. On the other hand we have now
established that the protein has a very similar charge and molecular
weight to FdI such that its apparent "association" with the FdI
ligand variants could be attributed to the coincidental copurification
of the two proteins. Indeed unlike the situation with FdI and its redox
partner NADPH:ferredoxin reductase (57), all attempts to obtain
cross-linked complexes of FdI and FdIV have been unsuccessful. Although
these observations do not rule out direct contact between the two
proteins, when combined with the observation that FdIV levels are
dramatically increased in the FdI minus strain LM100, they do provide
an alternative explanation, namely that FdIV levels are specifically
increased in response to deletion of FdI (or some function of FdI
disrupted in specific mutant strains). In this context it is important
to note that in A. vinelandii another protein, ferredoxin
reductase, has been shown to be overexpressed to the same levels via
the same specific DNA sequence, in response to either deletion of FdI
(33) or to addition of the superoxide propagator paraquat to cells
(86). This oxidative stress response system is described elsewhere
(86).3 Future experiments
will be directed toward examining the possibility that like the
fpr gene, the iscSUA-hscBA-fdxD gene
cluster, encoding proteins involved in [Fe-S] cluster assembly or
repair, might be similarly up-regulated in response to oxidative stress
or deletion of FdI.
 |
ACKNOWLEDGEMENTS |
We thank Professor Gordon Tollin, Dept. of
Chemistry, University of Arizona, Tucson, for generously providing
5'-deazariboflavin. We also thank Professor Yves Jouanneau,
Département de Biologie Moléculaire et Structurale/BBSI,
CEA-Grenoble, France, for sharing the information about molar
extinction coefficient of benzyl viologen.
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
Grant GM-45209 (to B. K. B.) and National Science Foundation Grant MCB-9630127 (to D. R. D.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Current address: Dept. of Microbiology and Molecular Genetics,
Harvard Medical School, 200 Longwood Ave., Boston, MA 02115.
To whom correspondence should be addressed: Dept. of Molecular
Biology and Biochemistry, University of California, Irvine, CA 92697. Tel.: 949-824-4297; Fax: 949-824-8551; E-mail: bburgess@uci.edu.
2
The redox potential of the [4Fe-4S] cluster of
FdI is too low to be reduced by dithionite so it is also not observed
in Fig. 9B.
3
Regnström, K, Sauge-Merle, S., Chen, K.,
and Burgess, B. K. (1999) Proc. Natl. Acad. Sci. U. S. A.,
in press.
 |
ABBREVIATIONS |
The abbreviations used are:
Fd, ferredoxin;
Eh, redox potential of the system relative to that
of a normal hydrogen electrode;
Em, midpoint redox
potential;
FPLC, high performance liquid chromatography;
MALDI, matrix-assisted laser desorption/ionization;
PCR, polymerase chain
reaction;
PAGE, polyacrylamide gel electrophoresis.
 |
REFERENCES |
| 1.
|
Mortenson, L. E.,
Valentine, R. C.,
and Carnahan, J. E.
(1962)
Biochem. Biophys. Res. Commun.
7,
448-452[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Lovenberg, W.
(ed)
(1973)
Iron-Sulfur Proteins
, Vols. I and II, Academic Press, New York
|
| 3.
|
Beinert, H.,
Holm, R. H.,
and Münck, E.
(1997)
Science
277,
653-659[Abstract/Free Full Text]
|
| 4.
|
Holm, R. H.,
Kennepohl, P.,
and Solomon, E. I.
(1996)
Chem. Rev.
96,
2239-2314[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Johnson, M. K.
(1994)
in
Encyclopedia of Inorganic Chemistry
(King, R. B., ed), Vol. 4
, pp. 1896-1915, Wiley Interscience, New York
|
| 6.
|
Cammack, R.
(1992)
Adv. Inorg. Chem.
38,
281-322
|
| 7.
|
Howard, J. B.,
and Rees, D. C.
(1991)
Adv. Protein Chem.
42,
199-280[Medline]
[Order article via Infotrieve]
|
| 8.
|
Beinert, H.
(1990)
FASEB J.
4,
2483-2491[Abstract]
|
| 9.
|
Lindahl, P. A.,
and Kovacs, J. A.
(1990)
J. Cluster Sci.
1,
29-73
|
| 10.
|
Beinert, H.,
Kennedy, M. C.,
and Stout, C. D.
(1996)
Chem. Rev.
96,
2335-2373[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Flint, D. H.,
and Allen, R. M.
(1996)
Chem. Rev.
96,
2315-2334[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Rouault, T. A.,
Haile, D. J.,
Downey, W. E.,
Philpott, C. C.,
Tang, C.,
Samaniego, F.,
Chin, J.,
Paul, I.,
Orloff, D.,
and Harford, J. B.
(1992)
Biometals
5,
131-140[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Hentze, M. W.,
and Kuhn, L. C.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
8175-8182[Abstract/Free Full Text]
|
| 14.
|
Beinert, H.,
and Kiley, P.
(1996)
FEBS Lett.
382,
218-219[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Gaudu, P.,
and Weiss, B.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
10094-10098[Abstract/Free Full Text]
|
| 16.
|
Hidalgo, E.,
Bollinger, J. M., Jr.,
Bradley, T. M.,
Walsh, C. T.,
and Demple, B.
(1995)
J. Biol. Chem.
270,
20908-20914[Abstract/Free Full Text]
|
| 17.
|
Khoroshilova, N.,
Beinert, H.,
and Kiley, P. J.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
2499-2503[Abstract/Free Full Text]
|
| 18.
|
Lazazzera, B. A.,
Beinert, H.,
Khoroshilova, N.,
Kennedy, M. C.,
and Kiley, P. J.
(1996)
J. Biol. Chem.
271,
2762-2768[Abstract/Free Full Text]
|
| 19.
|
Haile, D. J.,
Rouault, T. A.,
Harford, J. B.,
Kennedy, M. C.,
Blondin, G. A.,
and Klausner, R. D.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
11735-11739[Abstract/Free Full Text]
|
| 20.
|
Frey, P. A.,
and Reed, G. H.
(1993)
Adv. Enzymol. Relat. Areas Mol. Biol.
66,
1-39[Medline]
[Order article via Infotrieve]
|
| 21.
|
Reichard, P.
(1993)
J. Biol. Chem.
268,
8383-8386[Free Full Text]
|
| 22.
|
Staples, C. R.,
Ameyibor, E.,
Fu, W.,
Gardet-Salvi, L.,
Stritt-Etter, A.-L.,
Schürmann, P.,
Knaff, D. B.,
and Johnson, M. K.
(1996)
Biochemistry
35,
11425-11434[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Broderick, J. B.,
Duderstadt, R. E.,
Fernandez, D. C.,
Wojtuszewski, K.,
Henshaw, T. F.,
and Johnson, M. K.
(1997)
J. Am. Chem. Soc.
119,
7936-7937
|
| 24.
|
Peters, J. W.,
Lanzilotta, W. N.,
Lemon, B. J.,
and Seefeldt, L. C.
(1998)
Science
282,
1853-1858[Abstract/Free Full Text]
|
| 25.
|
Nicolet, Y.,
Piras, C.,
Legrand, P.,
Hatchikian, C. E.,
and Fontecilla-Camps, J. C.
(1999)
Structure
7,
13-23[Medline]
[Order article via Infotrieve]
|
| 26.
|
Matsubara, H.,
and Saeka, K.
(1992)
Adv. Inorg. Chem.
38,
223-280
|
| 27.
|
Chen, J. C.,
and Mortensen, L. E.
(1992)
Biochim. Biophys. Acta
1131,
122-124[Medline]
[Order article via Infotrieve]
|
| 28.
|
Shethna, Y. I.,
DerVartanian, D. V.,
and Beinert, H.
(1968)
Biochem. Biophys. Res. Commun.
31,
862-867[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Chatelet, C.,
and Meyer, J.
(1999)
J. Biol. Inorg. Chem.
4,
311-317[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Moshiri, F.,
Kim, J. W.,
Fu, C.,
and Maier, R. J.
(1994)
Mol. Microbiol.
14,
101-114[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Scherings, G.,
Haaker, H.,
and Veeger, C.
(1977)
Eur. J. Biochem.
77,
621-630
|
| 32.
|
Zheng, L.,
Cash, V. L.,
Flint, D. H.,
and Dean, D. R.
(1998)
J. Biol. Chem.
273,
13264-13272[Abstract/Free Full Text]
|
| 33.
|
Morgan, T. V.,
Lundell, D. J.,
and Burgess, B. K.
(1988)
J. Biol. Chem.
263,
1370-1375[Abstract/Free Full Text]
|
| 34.
|
Stephens, P. J.,
Jensen, G. M.,
Devlin, F. J.,
Morgan, T. V.,
Stout, C. D.,
Martin, A. E.,
and Burgess, B. K.
(1991)
Biochemistry
30,
3200-3209[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Yoch, D. C.,
and Arnon, D. I.
(1972)
J. Biol. Chem.
247,
4514-4520[Abstract/Free Full Text]
|
| 36.
|
Le, O.,
Shen, B.,
Iismaa, S. E.,
and Burgess, B. K.
(1993)
J. Bacteriol.
175,
7707-7710[Abstract/Free Full Text]
|
| 37.
|
Wientjens, R.
(1993)
Molecular Cloning of fix A, fix B, fix C, and fix X Genes of Azotobacter vinelandii
, PhD. thesis, Agricultural University, Wageningen, The Netherlands
|
| 38.
|
Jacobson, M. R.,
Brigle, K. E.,
Bennett, L. T.,
Setterquist, R. A.,
Wilson, M. S.,
Cash, V. L.,
Beynon, J.,
Newton, W. E.,
and Dean, D. R.
(1989)
J. Bacteriol.
171,
1017-1027[Abstract/Free Full Text]
|
| 39.
|
Raina, R.,
Bageshwar, U. K.,
and Das, H. K.
(1993)
Mol. Gen. Genet.
236,
459-462[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Raina, R.,
Reddy, M. A.,
Ghosal, D.,
and Das, H. K.
(1988)
Mol. Gen. Genet.
214,
121-127[CrossRef][Medline]
[Order article via Infotrieve]
|
| 41.
|
Rodríguez-Quiñones, F.,
Bosch, R.,
and Imperial, J.
(1993)
J. Bacteriol.
175,
2926-2935[Abstract/Free Full Text]
|
| 42.
|
Joerger, R. D.,
and Bishop, P. E.
(1988)
J. Bacteriol.
170,
1475-1487[Abstract/Free Full Text]
|
| 43.
|
Gao-Sheridan, H. S.,
Pershad, H. R.,
Armstrong, F. A.,
and Burgess, B. K.
(1998)
J. Biol. Chem.
273,
5514-5519[Abstract/Free Full Text]
|
| 44.
|
Reyntjens, B.,
Jollie, D. R.,
Stephens, P. J.,
Gao-Sheridan, H. S.,
and Burgess, B. K.
(1997)
J. Biol. Inorg. Chem.
2,
595-602[CrossRef]
|
| 45.
|
Ta, D. T.,
and Vickery, L. E.
(1992)
J. Biol. Chem.
267,
11120-11125[Abstract/Free Full Text]
|
| 46.
|
Martin, A. E.,
Burgess, B. K.,
Stout, C. D.,
Cash, V. L.,
Dean, D. R.,
Jensen, G. M.,
and Stephens, P. J.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
598-602[Abstract/Free Full Text]
|
| 47.
|
Iismaa, S. E.,
Vázquez, A. E.,
Jensen, G. M.,
Stephens, P. J.,
Butt, J. N.,
Armstrong, F. A.,
and Burgess, B. K.
(1991)
J. Biol. Chem.
266,
21563-21571[Abstract/Free Full Text]
|
| 48.
|
Shen, B.,
Martin, L. L.,
Butt, J. N.,
Armstrong, F. A.,
Stout, C. D.,
Jensen, G. M.,
Stephens, P. J.,
La Mar, G. N.,
Gorst, C. M.,
and Burgess, B. K.
(1993)
J. Biol. Chem.
268,
25928-25939[Abstract/Free Full Text]
|
| 49.
|
Shen, B.,
Jollie, D. R.,
Diller, T. C.,
Stout, C. D.,
Stephens, P. J.,
and Burgess, B. K.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
10064-10068[Abstract/Free Full Text]
|
| 50.
|
Kemper, M. A.,
Gao-Sheridan, H. S.,
Shen, B.,
Duff, J. L. C.,
Tilley, G. J.,
Armstrong, F. A.,
and Burgess, B. K.
(1998)
Biochemistry
37,
12829-12837[CrossRef][Medline]
[Order article via Infotrieve]
|